May 15, 2019

Latest Data on Evobrutinib, New MS Therapy Targeting B Cells

Posted by in category: biotech/medical

Further data from the phase 2 trial of show a significant reduction in enhancing MRI lesions with one of the doses tested but increases in liver enzymes may be an issue.

Read more

Comments are closed.